DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Baird Maintains Outperform on Alexion Pharmaceuticals, Lowers Price Target to $140

Baird maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and lowers the price target from $165 to $140.

Benzinga · 01/31/2020 14:05

Baird maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and lowers the price target from $165 to $140.